Skip to main content
Log in

A double-blind, randomized, placebo-controlled trial of n-3 fatty acid based lipid infusion in acute, extended guttate psoriasis

Rapid improvement of clinical manifestations and changes in neutrophil leukotriene profile

  • Clinical Pharmacology Original Article
  • Published:
The clinical investigator Aims and scope Submit manuscript

Summary

Twenty patients hospitalized for acute psoriasis guttata with a minimum 10% of body surface area involvement (range 10–90%) completed a 10-day trial in which they were randomly allocated to receive daily infusions with either an n-3 fatty acid based lipid emulsion [100 ml/day with 2.1 g eicosapentaenoic (EPA) and 21 g docosahexaenoic acid (DHA)] or a conventional n-6 lipid emulsion (EPA+DHA<0.1 g/100 ml). The severity of disease was evaluated by scoring daily erythema, infiltration, and desquamation and by a subjective scoring of clinical manifestations offered by the patients. Leukotriene (LT) and platelet-activating factor (PAF) generation were investigated in ionophore-stimulated neutrophils obtained on days 0, 1, 3, 5, 10, and 40. Moderate improvement in clinical manifestations was noted in the n-6 group (changes in score systems between 16–25% from baseline within 10 days). In contrast, the severity of disease markedly decreased in all patients of the n-3 group, with improvements in all score systems ranging between 45% and 76% within 10 days (P<0.05 for each variable). The difference in response to the two regimens was evident within 4–7 days after onset of lipid infusion. A more than ten fold increase in neutrophil EPA-derived 5-1ipoxygenase product formation (LTB5, its omega-oxidation products, non-enzymatic degradation products of LTA5 and 5-hydroxyeicosapentaenoic acid) was noted in the n-3 group but not in the n-6 group. Neutrophil PAF generation increased in the n-6 group but decreased in the n-3 group. In conclusion, modulation of eicosanoid metabolism by intravenous n-3 fatty acid supplementation appears to exert a rapid beneficial effect on inflammatory skin lesions in acute guttate psoriasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

AA:

arachidonic acid

DHA:

docosahexaenoic acid

EPA:

eicosapentaenoic acid

5-HEPE:

5-hydroxyeicosapentaenoic acid

5-HETE:

5-hydroxyeicosatetraenoic acid

LT:

leukotriene

PAF:

platelet activating factor

PMN:

polymorphonuclear leukocyte

References

  1. Bittiner SB, Tucker WE, Cartwight I, Bleehan SS (1988) A double-blind, randomised, placebo-controlled trial of fish oil in psoriasis. Lancet I:378–380

    Google Scholar 

  2. Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:753–757

    Google Scholar 

  3. Brain SD, Camp RDR, Dowd PM (1982) Psoriasis and leukotriene B4. Lancet II:762–763

    Google Scholar 

  4. Brain SD, Camp RDR, Dowd PM, Black AK, Greaves M (1984) The release of leukotriene B4-like material in biologically active amounts from the lesional skin of patients with psoriasis. J Invest Dermatol 83:70–73

    Google Scholar 

  5. Christophers E (1989) Regulative Faktoren der psoriatischen Hautreaktion. Hautarzt 40:456–460

    Google Scholar 

  6. Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JW, Cannon JG, Rogers TS, Klempner MS, Weber PC (1989) The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 320:265–271

    Google Scholar 

  7. Fisher M, Upchurch KS, Levine PH, Johnson MH, Vaudreuil CH, Natale A, Hoogasian JJ (1986) Effects of dietary fish oil supplementation on polymorphonuclear leukocyte inflammatory potential. Inflammation 10:387–392

    Google Scholar 

  8. Fogh K, Herlin T, Kragballe K (1989) Eicosanoids in acute and chronic psoriatic lesions: leukotriene B4, but not 12-hydroxy-eicosatentraenoic acid is present in biologically active amounts in acute guttate lesions. J Invest Dermatol 92:837–841

    Google Scholar 

  9. Ford-Hutchinson AW, Bray MA, Doig MW, Shipley ME, Smith HJH (1980) Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 286:264–265

    Google Scholar 

  10. Georgilis K, Klempner MS (1988) In vitro effects of omega-3 fatty acids on neutrophil intracellular calcium homoeostasis and receptor expression for FMLP and LTB4. Inflammation 12:475–490

    Google Scholar 

  11. Goldman DW, Pickett WC, Goetzl EJ (1983) Human neutrophil chemotactic and degranulating activities of leucotriene B5 (LTB5) derived from eicosapentaenoic acid. Biochem Biophys Res Commun 117:282–288

    Google Scholar 

  12. Grabbe J, Czarnetzki BM, Mardin M (1982) Chemotactic leukotrienes in psoriasis. Lancet Dec 25:1464

    Google Scholar 

  13. Grabbe J, Czarnetzki BM, Mardin M (1984) Release of lipoxygenase products of arachidonic acid from freshly isolated human keratinocytes. Arch Dermatol Res 276:128–130

    Google Scholar 

  14. Grabbe J, Czarnetzki BM, Rosenbach T, Mardin M (1984) Identification of chemotactic lipoxygenase products of arachidonate metabolism in psoriatic skin. J Invest Dermatol 82:477–479

    Google Scholar 

  15. Grimminger F, Becker G, Seeger W (1988) High yield enzymatic conversion of intravascular leukotriene A4 in blood-free perfused lungs. J Immunol 141:2431–2436

    Google Scholar 

  16. Grimminger F, Menger M, Becker G, Seeger W (1988) Potentiation of leukotriene generation following sequestration of neutrophils in isolated lungs. Blood 72:1687–1692

    Google Scholar 

  17. Grimminger F, Sibelius U, Aktories K, Seeger W (1991) Inhibition of cytoskeletal rearrangement by Botulinum C2 toxin amplifies ligand-evoked lipid mediator generation in human neutrophils. Mol Pharmacol 40:563–571

    Google Scholar 

  18. Grimminger F, Sibelius U, Bhakdi S, Suttorp N, Seeger W (1991) Escherichia coli hemolysin-induced secretory responses and PAF generation in human neutrophils is related to phosphoinositide hydrolysis. J Clin Invest 88:1531–1539

    Google Scholar 

  19. Grimminger F, Dürr U, Seeger W (1992) Ligand-operated synthesis of 4-series and 5-series leukotrienes in human neutrophils: critical dependence on exogenous free fatty acid supply. Mol Pharmacol 41:757–766

    Google Scholar 

  20. Gupta AK, Ellis CN, Tellner DC, Anderson TF, Vortices JJ (1989) Double-blind, placebo-controlled study to evaluate the efficacy of fish oil and low-dose UVB in the treatment of psoriasis. Br J Dermatol 120:801–807

    Google Scholar 

  21. Heidel JR, Taylor SM, Laegreid WW, Silflow RM, Liggitt HD, Leid RW (1989) In vivo chemotaxis of bovine neutrophils induced by 5-lipoxygenase metabolites of arachidonic and eicosapentaenoic acid. Am J Pathol 134:671–676

    Google Scholar 

  22. Hjorth R, Jonsson AK, Vretblad P (1981) A rapid method for purification of human granulocytes using Percoll. A comparison with dextran sedimentation. J Immunol Methods 43:95–99

    Google Scholar 

  23. Kettler AH, Baughn RE, Orengo IF, Black H, Wolf JE (1988) The effect of dietary fish oil supplementation on psoriasis. J Am Acad Dermatol 88:1267–1273

    Google Scholar 

  24. Kojima T, Terano T, Tanabe E, Okamoto S, Tamura Y, Yoshida S (1991) Long-term administration of highly purified eicosapentaenoic acid provides improvement of psoriasis. Dermatologica 182:225–230

    Google Scholar 

  25. Kragballe K, Herlin T (1983) Benoxaprofen improves psoriasis: a double-blind study. Arch Dermatol 119:548–552

    Google Scholar 

  26. Kragballe K, Vortices JJ (1985) Arachidonic acid in psoriasis. Pathogenic role and pharmacological regulation. Acta Derm Venereol Suppl (Stockh) 120:12–17

    Google Scholar 

  27. Kragballe K, Fogh K (1989) A low-fat diet supplemented with dietary fish oil (Max-EPA) results in improvement of psoriasis and formation of leukotriene B5. Acta Derm Venereol (Stockh) 69:23–28

    Google Scholar 

  28. Kragballe K, Vorhees JJ, Goetzl EJ (1987) Inhibition by leucotriene BS of leucotriene B4-induced activation of human keratinocytes and neutrophils. J Invest Dermatol 88:555–558

    Google Scholar 

  29. Kremer JM, Jubiz W, Michalek A, Rynes RI, Bartholomew LE, Bigaouette J, Timchalk M, Beeler D, Lininger L (1987) Fish-oil fatty acid supplementation in active rheumatoid arthritis: a double-blind, controlled, cross-over study. Ann Intern Med 106:497–503

    Google Scholar 

  30. Lassus A, Forsstrom SA (1985) A dimethoxynaphtalene derivative (RS-43179 gel) compared with 0.025% flucinolone acetonide gel in the treatment of psoriasis. Br J Dermatol 113:103–106

    Google Scholar 

  31. Leaf A, Weber PC (1988) Medical progress: cardiovascular effects of n-3 fatty acids. N Engl J Med 318:549–557

    Google Scholar 

  32. Lee TH, Mencia-Huerta JM, Shih C, Corey E, Lewis RA, Austen FK (1984) Characterization and biologic properties of 5,12-dihydroxy-derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase products. J Biol Chem 259:2383–2389

    Google Scholar 

  33. Lee TH, Hoover RL, Williams JD, Sperling RI, Ravalese J, Spur BW, Robinson DR, Corey EJ, Lewis RA, Austen KF (1985) Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 312:1217–1224

    Google Scholar 

  34. Lee TH, Sehti T, Crea AE, Peters W, Arm JP, Horton CE, Walport MJ, Spur BW (1988) Characterization of leukotriene B3: comparison of its biological activities with leukotriene B4 and leukotriene B5 in complement receptor enhancement, lysozyme release and chemotaxis of human neutrophils. Clin Sci 74:467–475

    Google Scholar 

  35. Mascioli EA, Lopes S, Randall S, Porter KA, Kater G, Hirschberg Y, Babayan VK, Bistrian BR, Blackburn GL (1989) Serum fatty acid profiles after intravenous medium chain triglyceride administration. Lipids 24:793–798

    Google Scholar 

  36. Maurice PD, Allen BR, Barkley AS, Cockbill SR, Stammers J, Bather PC (1987) The effects of dietary supplementation with fish oil in patients with psoriasis. Br J Dermatol 117:599–606

    Google Scholar 

  37. Mehta JL, Lopez LM, Lawson D, Wargovich TJ, Williams LL (1988) Dietary supplementation with omega-3 polyunsaturated fatty acids in patients with stable coronary heart disease: effects on indices of platelet and neutrophil function and exercise performance. Am J Med 84:45–52

    Google Scholar 

  38. Payan DG, Wong MY, Chernov-Rogan T, Valone FH, Pickett WC, Blake VA, Gold WM, Goetzl EJ (1986) Alteration in human leukocyte function induced by ingestion of eicosapentaenoic acid. J Clin Immunol 6:402–410

    Google Scholar 

  39. Prescott SM, Zimmermann GA, Morrison AR (1985) The effects of a diet rich in fish oil on human neutrophils: identification of leukotriene BS as a metabolite. Prostaglandins 30:209–227

    Google Scholar 

  40. Rosenbach T, Czernielewski J, Hecker M, Czarnetzki BM (1990) Comparison of eicosanoid generation by highly purified human Langerhans cells and keratinocytes. J Invest Dermatol 95:104–105

    Google Scholar 

  41. Ruzicka T (1988) The physiology and pathophysiology of eicosanoids in the skin. Eicosanoids 1:59–72

    Google Scholar 

  42. Ruzicka T, Groß E (1989) Pharmacologic effects of linoleic acid (LA) in skin and polymorphonuclear leukocytes. J Invest Dermatol 92:510

    Google Scholar 

  43. Samuelsson B, Dahlen SE, Lindgren JA, Rouzer CA, Serhan CN (1987) Leukotrienes and lipoxins: structures, biosynthesis and biological effects. Science 237:1171–1178

    CAS  PubMed  Google Scholar 

  44. Seeger W, Suttorp N, Hellwig A, Bhakdi S (1986) Noncytolytic terminal complement complexes may serve as calcium gates to elicit leukotriene B4 generation in human polymorphonuclear leukocytes. J Immunol 137:1286–1293

    Google Scholar 

  45. Takematsu H, Terui T, Tagami H (1986) Demonstration of leukotriene B4 in the scale extracts of psoriasis and inflammatory pustular dermatoses. Acta Derm Venereol (Stockh) 66:6–10

    Google Scholar 

  46. Tessner TG, O'Flaherta JT, Wykle RL (1989) Stimulation of platelet-activating factor synthesis by a nonmetabolizable bioactive analog of platelet-activating factor and influence of arachidonic acid metabolites. J Biol Chem 264:4794–4799

    Google Scholar 

  47. Urakaze M, Hamazaki T, Makuta M, Ibuki F, Kobayashi S, Yano S, Kumagai A (1987) Infusion of fish oil emulsion: effect on platelet aggregation and fatty acid composition in phospholipids of plasma platelets and red blood cell membranes in rabbits. Am J Clin Nutr 46:936–940

    Google Scholar 

  48. Virella G, Kilpatrick JM, Rugeles MT, Hyman B, Russell R (1989) Depression of Immoral responses and phagocytic functions in vivo and in vitro by fish oil and eicosapentaenoic acid. Clin Immunol Immunopathol 52:257–270

    Google Scholar 

  49. Vorhees JJ (1986) Leukotrienes and other lipoxygenase products in the pathogenesis and therapy of psoriasis and other dermatoses. Arch Dermatol 122:1277–1282

    Google Scholar 

  50. Weber PC, Fischer S, Schacky CV, Lorenz R, Strasser T (1986) The conversion of dietary eicosapentanoic acid to prostanoids and leukotrienes in man. Prog Lipid Res 25:273–276

    Google Scholar 

  51. Yamazaki K, Hamazaki T, Yano S, Funada T, Ibuki F (1991) Changes in fatty acid composition in rat blood and organs after infusion of docosahexaenoic acid ethyl ester. Am J Clin Nutr 53:620–627

    Google Scholar 

  52. Ziboh VA, Cohn KA, Ellis CN (1986) Effects of dietary supplementation of fish oil on neutrophil and epidermal fatty acids — modulation of clinical course of psoriatic subjects. Arch Dermatol 122:1277–1282

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

The study was supported by the Deutsche Forschungsgemeinschaft (DFG La 73/20-1)

The manuscript includes portions of the doctoral thesis of C. Papavassilis

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grimminger, F., Mayser, P., Papavassilis, C. et al. A double-blind, randomized, placebo-controlled trial of n-3 fatty acid based lipid infusion in acute, extended guttate psoriasis. Clin Investig 71, 634–643 (1993). https://doi.org/10.1007/BF00184491

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00184491

Key words

Navigation